Surgical Management of Malignant Tumors of the Trachea: Report of Two Cases and Review of Literature by Yasumatsu, Ryuji et al.
 
Case Rep Oncol 2012;5:302–307 
DOI: 10.1159/000339408 
Published online: 
June 12, 2012 
© 2012 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
This is an Open Access article licensed under the terms of the Creative Commons 
Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable 
to the online version of the article only. Distribution for non-commercial purposes only.   
 
                      Ryuji Yasumatsu, MD    Department of Otorhinolaryngology, Graduate School of Medical Sciences 
Kyushu University 
3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582 (Japan) 
Tel. +81 92 642 5668, E-Mail yasuryuj @ qent.med.kyushu-u.ac.jp 
 
302 
   
Surgical Management of 
Malignant Tumors of the 
Trachea: Report of Two Cases 
and Review of Literature 
Ryuji Yasumatsu
a    Junichi Fukushima
c    
Torahiko Nakashima
c    Hideki Kadota
c    Yuichi Segawa
a    
Akihiro Tamae
a    Masato Kato
b    Shizuo Komune
c 
Departments of 
aOtorhinolaryngology and 
bSurgery, Hamanomachi Hospital, 
and 
cDepartment of Otorhinolaryngology, Graduate School of Medical 
Sciences, Kyushu University, Fukuoka, Japan 
 
 
Key Words 
Tracheal cancer · Squamous cell carcinoma · Adenoid cystic carcinoma · Mediastinal 
tracheostomy 
 
 
Abstract 
Malignant neoplasms occurring from the trachea are extremely rare. Therefore, their clinical 
characteristics and surgical results have not been thoroughly discussed. These tumors are 
often misdiagnosed and treated as bronchial asthma or chronic obstructive pulmonary 
disease. It is critically important to probe the cause-effect relationship between the medical 
presentations and the clinical diagnosis. In this report, two cases of tracheal malignancy 
suffering from dyspnea due to obstruction of the proximal trachea are described, and a 
review of the literature is presented. 
 
Introduction 
Malignant neoplasms of the trachea are extremely rare. Grillo and Mathisen [1] 
reported that tracheal tumors account for only 2% of all lung tumors. Therefore, their 
clinical characteristics and surgical results have not been thoroughly discussed. In 
addition, there are extremely variable clinical and histological features [2, 3]. These 
tumors are often diagnosed late on account of delayed specific symptoms (blood 
sputum, coughing, dyspnea) [4–6]. The patients are often treated as bronchial asthma 
patients, and this misdiagnosis delays the proper treatment, leading to the inoperability 
of the tumor.  
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The present study reports two cases of tracheal malignancy suffering from dyspnea 
due to obstruction of the airways and describes the clinical features of this rare disease.  
Case Reports 
Case 1 
A 58-year-old man with a history of 40 cigarettes per day for 35 years presented to our hospital 
complaining of blood-streaked sputum and dyspnea. Two years before, he had suffered from laryngeal 
carcinoma and underwent radiotherapy (66 Gy) to the larynx in another hospital. A computed 
tomography (CT) and bronchoscopy documented a cauliflower-like, warty tumor (fig. 1a, b). The 
main tumors were located 25 and 50 mm below the vocal cords. Biopsy revealed squamous cell 
carcinoma (SCC). It was difficult to determine whether the tumor was a primary tracheal tumor or a 
recurrence of the previously treated laryngeal cancer. We started tracheostomy under local 
anesthesia to remove the tumors and secure his airways. After completing  tracheostomy, radical 
surgery was carried out. The gross tumor extension did not exceed 5 cm up to the carina. However, 
the residual trachea was too short to perform a standard tracheostoma, and we decided to resect the 
manubrium, the clavicular head and the first costal cartilages to perform a mediastinal tracheostomy, 
as described by Grillo [7]. We performed the relocation of the trachea inferior to the innominate 
artery to avoid a potentially hazardous ligation of this vessel. The mediastinal stoma and upper 
mediastinal defect were covered by a pectoralis major myocutaneous flap, as described by Biller et al. 
in 1980 [8]. This confident flap provided well-vascularized muscle to fill the dead space in the upper 
mediastinum and created a bulky interposition between the trachea and innominate artery (fig. 2a, 
b). The postoperative course was uneventful and the patient was discharged home on the 20th 
postoperative day. The patient had an excellent long term outcome, and there was no evidence of 
recurrence after 20 months of follow-up. 
Case 2 
A 58-year-old woman presented with cough and breathlessness of 2 weeks duration. She denied a 
history of chest pain, hemoptysis, dysphagia and hoarsness of voice. Local examination of her neck 
revealed a 4 × 3 cm firm, nontender swelling fixed to the underlying structures. Other systemic 
examination was unremarkable. The patient was referred for fine needle aspiration cytology. 
Cytological findings revealed adenoid cystic carcinoma (ACC). Fiberoptic bronchoscopy was 
performed which showed a well-defined, solitary, smooth-surfaced mass at the anterior wall of the 
trachea. A CT showed a voluminous, wall-thickening, and solid tracheal mass of about 3–4 cm in 
length, extending from the subglottic space to the cervical trachea (fig. 3a, b). We performed a 
tracheostomy under local anesthesia to secure her airways. After completing tracheostomy, an open 
biopsy was performed and histological findings revealed ACC. The patient underwent 
pharyngolaryngectomy, right neck dissection, and microvascular free jejunal transfer (fig. 4a, b). No 
perioperative and postoperative complications occurred and there was no evidence of recurrence 
after 18 months of follow-up. 
Discussion 
Tracheal tumors are rare and account for only 2% of all respiratory tract tumors. A 
variety of histological features of tracheal tumors have been reported, including benign, 
low-grade, and high-grade malignancies [4, 9].  
SCC is the most common tracheobronchial malignancy and develops mainly in the 
6th and 7th decades of life. This tumor is strongly associated with habitual cigarette 
smoking, affecting men two to four times more frequently than women [9, 10]. 
Approximately 40% of all tracheobronchial SCCs have been reported to occur before, 
concurrently with, or after carcinoma of the oropharynx, larynx, or lung. Our first case 
had a history of radiotherapy for laryngeal cancer.  
Case Rep Oncol 2012;5:302–307 
DOI: 10.1159/000339408 
Published online: 
June 12, 2012 
© 2012 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
 
 
 
304 
ACC is the second most common tracheal malignancy determined at histology after 
SCC [10, 11]. ACC tends to occur in the central airways such as the trachea, main 
bronchus, or lobar bronchus; a peripheral or segmental location is uncommon. These 
tumors are generally thought to have low-grade malignant potential; however, they 
have a tendency for local recurrence and late development of distant metastasis. 
Because of their slow progression, these tumors cannot give any symptoms until airway 
obstruction occurs. 
Common symptoms of tracheal malignancies include breathlessness, cough, 
hemoptysis, dysphagia, and stridor. However, these tumors are sometimes 
misdiagnosed because the symptoms can mimic those of asthma or chronic obstructive 
pulmonary disease [3, 12]. Our ACC case was also treated first as an asthma patient for 
2 months. 
Rapid evaluation of the tumor (severity of tracheal stenosis, location, length, and 
invasion status) and the possibility for surgical resection is the most important strategy 
for patients with stenosis of the central airways due to tracheal tumors. CT is a useful 
imaging procedure for tracheal tumors [13]. The conventional CT scan of the chest and 
trachea is recommended for this kind of tumor, and endoscopic examination is the best 
way to evaluate obstruction. 
A complete resection, if possible, provides the best potential benefit as well as 
symptomatic relief for patients with primary tracheal tumors such as SCC and ACC [14, 
15]. However, because tumors with malignant potential tend to infiltrate along the 
airways, they are often incompletely resected and thus prone to recur locally. The 
complete resection rates in reported cases range from 42 to 57%. In our cases, we 
could treat the patients surgically by the total removal of the larynx and its 
reconstruction, performing mediastinal tracheostomy (first case) or 
pharyngolaryngectomy (second case). External beam irradiation has commonly been 
used for palliative treatment of tracheal cancer and its palliative potential is reasonable 
[16]. Several studies have demonstrated the value of radiotherapy in controlling 
primary tumors of the trachea, providing good palliation in 75% of the patients and a 5-
year survival rate of up to 10% [17, 18]. 
Prognosis of patients with tumors of the trachea remains poor. Extensive resection 
provides disease control and allows to obtain 5-year survivals for 20–40% of the SCC 
patients and 60–100% of the ACC cases[1, 19]. 
In conclusion, we reported two cases of tracheal cancer with stenosis of the proximal 
trachea. It is critically important to probe the cause-effect relationship between the 
medical presentations and the clinical diagnosis. Failure to respond to general therapy 
suggests that the primary diagnosis should be suspected. A smoker presenting dyspnea 
could be carrier of a tracheal neoplasm, and early diagnosis is very important for its 
management. 
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Fig. 1. a Tumors are located 25 and 50 mm below the vocal cord (arrows). b Bronchoscopic 
examination reveals papillomatous tumors under the subglottis. 
 
 
 
Fig. 2. a Operation view of the tracheal stump after its relocation inferior to the innominate artery 
(arrow). b Reconstruction of the cervical and upper mediastinal defects using a pectoralis major 
myocutaneous flap. 
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Fig. 3. a The tumor is located in the posterolateral wall of the trachea (arrow). b Coronal view. The 
arrow indicates the tumor. c Bronchoscopic examination reveals a smooth mass under the subglottis, 
with obstruction of the lumen. 
 
 
 
Fig. 4. a Operation view of the cervical tumor (ACC) before the open biopsy (arrow) was performed. 
b Reconstruction of the hypopharynx and cervical esophagus using free jejunal transfer. 
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